IL157357A0 - A pharmaceutical kit containing tegafur, uracil, folinic acid, paclitaxel and carboplatin - Google Patents

A pharmaceutical kit containing tegafur, uracil, folinic acid, paclitaxel and carboplatin

Info

Publication number
IL157357A0
IL157357A0 IL15735702A IL15735702A IL157357A0 IL 157357 A0 IL157357 A0 IL 157357A0 IL 15735702 A IL15735702 A IL 15735702A IL 15735702 A IL15735702 A IL 15735702A IL 157357 A0 IL157357 A0 IL 157357A0
Authority
IL
Israel
Prior art keywords
carboplatin
paclitaxel
uracil
kit containing
folinic acid
Prior art date
Application number
IL15735702A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL157357A0 publication Critical patent/IL157357A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15735702A 2001-03-06 2002-03-04 A pharmaceutical kit containing tegafur, uracil, folinic acid, paclitaxel and carboplatin IL157357A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27357701P 2001-03-06 2001-03-06
PCT/US2002/006262 WO2002076459A1 (en) 2001-03-06 2002-03-04 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin

Publications (1)

Publication Number Publication Date
IL157357A0 true IL157357A0 (en) 2004-02-19

Family

ID=23044526

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15735702A IL157357A0 (en) 2001-03-06 2002-03-04 A pharmaceutical kit containing tegafur, uracil, folinic acid, paclitaxel and carboplatin

Country Status (20)

Country Link
US (1) US6770653B2 (is)
EP (1) EP1368034A1 (is)
JP (1) JP2005506294A (is)
KR (1) KR20030081496A (is)
BR (1) BR0207443A (is)
CA (1) CA2439676A1 (is)
CZ (1) CZ20032266A3 (is)
EE (1) EE200300429A (is)
HR (1) HRP20030801A2 (is)
HU (1) HUP0303466A3 (is)
IL (1) IL157357A0 (is)
IS (1) IS6925A (is)
MX (1) MXPA03007989A (is)
NO (1) NO20033910L (is)
PL (1) PL363967A1 (is)
RU (1) RU2284184C2 (is)
SK (1) SK10602003A3 (is)
WO (1) WO2002076459A1 (is)
YU (1) YU69903A (is)
ZA (1) ZA200306541B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE495793T1 (de) * 2000-11-06 2011-02-15 Pharma Mar Sa Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
NZ542150A (en) 2003-03-14 2009-09-25 Taiho Pharmaceutical Co Ltd Antitumor effect potentiator and antitumor agent
WO2004087105A1 (en) * 2003-04-02 2004-10-14 Celator Pharmaceuticals, Inc. Combination formulations of platinum agents and fluoropyrimidines
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
EP1691809A1 (en) * 2003-11-14 2006-08-23 Pharma Mar, S.A. Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
KR20050099311A (ko) * 2004-04-09 2005-10-13 에이엔에이치 케어연구소(주) 주사제용 항암제 조성물
PT1827500E (pt) * 2004-10-26 2009-08-05 Pharma Mar Sa Doxorrubicina pegilada lipossomal em combinação com ecteinescidina 743
RS50510B (sr) 2004-10-29 2010-03-02 Pharma Mar S.A., Sociedad Unipersonal Formulacije koje sadrže ekteinascidin i disaharid
US8735394B2 (en) 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
CA3054535A1 (en) 2005-02-18 2006-08-24 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CA2703026A1 (en) * 2007-10-19 2009-04-23 Rafael Rosell Costa Prognostic molecular markers for et-743 treatment
EP2552415B1 (en) 2010-03-29 2016-09-07 Abraxis BioScience, LLC Methods of treating cancer
MX2012011155A (es) 2010-03-29 2012-12-05 Abraxis Bioscience Llc Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos.
NZ706745A (en) 2010-06-04 2017-01-27 Abraxis Bioscience Llc Methods of treatment of pancreatic cancer
WO2016172393A1 (en) * 2015-04-22 2016-10-27 Syn-Nat Products Enterprise LLC Co-crystal composition and its pharmaceutical use
SG11201901815WA (en) 2016-08-31 2019-04-29 Fujifilm Corp Anti-tumor agent, anti-tumor effect enhancer, and anti-tumor kit
RU2646450C1 (ru) * 2017-05-11 2018-03-05 Владимир Михайлович Курусин Способ лечения предраковых и ранних стадий раковых заболеваний желудка
WO2019146130A1 (ja) 2018-01-29 2019-08-01 富士フイルム株式会社 胆道がん用抗腫瘍剤および胆道がんの処置方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328229A (en) 1978-03-29 1982-05-04 Taiho Pharmaceutical Company Limited Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
US5534513A (en) 1991-09-05 1996-07-09 Taiho Pharmaceutical Company, Ltd. Antitumor potentiator and antitumor composition
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
US5919816A (en) * 1994-11-14 1999-07-06 Bionumerik Pharmaceuticals, Inc. Formulations and methods of reducing toxicity of antineoplastic agents

Also Published As

Publication number Publication date
NO20033910D0 (no) 2003-09-04
YU69903A (sh) 2006-08-17
WO2002076459A1 (en) 2002-10-03
HUP0303466A3 (en) 2005-02-28
KR20030081496A (ko) 2003-10-17
ZA200306541B (en) 2004-11-22
NO20033910L (no) 2003-10-23
US20020173482A1 (en) 2002-11-21
RU2284184C2 (ru) 2006-09-27
EP1368034A1 (en) 2003-12-10
US6770653B2 (en) 2004-08-03
JP2005506294A (ja) 2005-03-03
IS6925A (is) 2003-08-22
PL363967A1 (en) 2004-11-29
HUP0303466A2 (hu) 2004-01-28
CZ20032266A3 (cs) 2004-02-18
HRP20030801A2 (en) 2004-08-31
SK10602003A3 (en) 2004-10-05
CA2439676A1 (en) 2002-10-03
RU2003129527A (ru) 2005-03-10
BR0207443A (pt) 2004-04-06
EE200300429A (et) 2003-12-15
MXPA03007989A (es) 2003-12-04

Similar Documents

Publication Publication Date Title
IL157357A0 (en) A pharmaceutical kit containing tegafur, uracil, folinic acid, paclitaxel and carboplatin
HUS2200038I1 (hu) HIV-gátló pirimidinszármazékok
HK1149574A1 (en) Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
HUP0301722A3 (en) Pyrimidine derivatives, pharmaceutical compositions containing them and their use
IL191790A0 (en) Xanthine derivatives, production and use thereof as a medicament
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HK1078783A1 (en) Multistage formulation containing a biguanide and thiazolidindione derivatives
ZA200210411B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
HUP0303082A3 (en) Substituted indoleoxoacetic piperazine derivatives, pharmaceutical compositions containing them and their antiviral use
ZA200210180B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
HUP0304048A2 (hu) Szubsztituált pirazinon-, piridin- és pirimidinszármazékok és alkalmazásuk kortikotropin-felszabadító faktor ligandumokként és ezeket tartalmazó gyógyszerkészítmények
HK1091208A1 (en) Pyrimidinone derivatives and 3-ketoester
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
MXPA03007320A (es) Nuevos compuestos de pirimidina.
MXPA03008338A (es) Derivados de piperazina.
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
HUP0303593A3 (en) Biguanide derivatives, pharmaceutical compositions containing them and their use
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
AU2001240001A1 (en) Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
HUP0400444A3 (en) Carbapenem compound, pharmaceutical compositions containing them and their use
HK1060730A1 (en) Substititud propane-1,3-diamine derivatives and t he pharmaceutical use thereof
AU2002361988A1 (en) Pharmaceutical containing n, n'-disubstituted piperazine compounds
ZA200203086B (en) Pyrimidin-4-one compounds, a process for their preparation and pharmaceutical compositions containing them.
IL160606A0 (en) C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals